Navigation Links
OncoSec Medical Announces $7.2 Million Public Offering
Date:12/13/2012

SAN DIEGO, Dec. 13, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced today that it has entered into definitive agreements with institutional investors to purchase approximately $7.2 million of securities in a registered public offering. OncoSec has agreed to sell to institutional investors an aggregate of 28,800,000 shares of its common stock at $0.25 per share. Additionally, investors will receive warrants to purchase up to 14,400,000 shares of common stock at an exercise price of $0.26 per share for a term of four years.

(Logo: http://photos.prnewswire.com/prnh/20110314/MM64943LOGO)

The gross proceeds of the offering are expected to be approximately $7.2 million. Net proceeds, after deducting the placement agent's fee and other estimated offering expenses payable by OncoSec, are expected to be approximately $6.5 million.

OncoSec intends to use proceeds from the offering for general corporate purposes, including clinical trial expenses and research and development expenses.

Dawson James Securities, Inc. acted as the exclusive placement agent for the transaction.  Burrill LLC and Noble Financial Capital Markets acted as financial advisors to OncoSec in connection with the transaction.

The offering is expected to close on December 17, 2012, subject to customary closing conditions.

The securities described above are being offered by OncoSec pursuant to a registration statement previously filed and declared effective by the Securities and Exchange Commission, or the SEC. A prospectus supplement related to the offering will be filed with the SEC. The securities may only be offered by means of a prospectus. Copies of the prospectus and prospectus supplement can be obtained directly from OncoSec and at the
'/>"/>

SOURCE OncoSec Medical Incorporated
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
2. OncoSec Medical Issues Letter to Shareholders
3. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
4. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
5. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
6. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
7. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
8. OncoSec Granted New Patent from China
9. OncoSec to Present at Upcoming Healthcare and Investor Conferences
10. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
11. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... 19, 2014 You,re visiting the dentist for ... when he or she says you need a root ... you may have several questions and feel apprehensive about ... know it,s nothing to worry about. The Pennsylvania Dental ... alleviate any anxiety the public may have surrounding this ...
(Date:12/19/2014)... 2014 In today,s increasingly global marketplace ... to reflect the needs of a global marketplace ... the needs of key stakeholders while recognizing regional ... According to recent research by benchmarking firm, Best ... companies averaged more than $100,000 in annual spending ...
(Date:12/19/2014)... December 18, 2014 Radiology ... that is used to store, manipulate, and distribute ... a patient tracking and scheduling system, result reporting, ... RIS with HIS and other databases improves the ... and patient scheduling, patient list management, radiology department ...
Breaking Medicine Technology:Root Canals Have Become More Routine 2Building a Best-in-Class Pharma Global Brand Website 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 2The Global Radiology Information Systems Market is Expected to Grow at a CAGR of 7.5% from 2014 to 2019 3
... Dec. 22 Prasco Laboratories announced today that they have ... a GlaxoSmithKline company, for Clobetasol Propionate Foam 0.05%, the latest ... of the agreement, Prasco will market and distribute Clobetasol Propionate ... under the Prasco label. , "We are pleased to provide ...
... , , SANTA CLARA, Calif., Dec. 22 NewCardio, Inc., ... today announced that Dr. Ihor Gussak, Ph.D., F.A.C.C., NewCardio,s Vice ... of speakers, moderators and panelists at the Center for Business ... is scheduled for January 12 and 13, 2010, at the ...
Cached Medicine Technology:Prasco and Stiefel Sign Distribution and Supply Agreement for Clobetasol Propionate Foam 2Prasco and Stiefel Sign Distribution and Supply Agreement for Clobetasol Propionate Foam 3NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit 2NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit 3NewCardio to Sponsor and Present at 4th Annual Cardiac Safety Assessment Summit 4
(Date:12/19/2014)... -- All children should have their eyesight checked between ... eye experts say. The new vision-screening guidelines for ... U.S. National Center for Children,s Vision Health. The ... screening for eye problems, particularly vision issues that ... and strabismus (a disorder of eye alignment). Early ...
(Date:12/19/2014)... News) -- The cost of cancer treatment can cause ... finds. Researchers examined data from 1,000 people in ... or lung cancer. Of those patients, almost 900 had ... 100 had advanced cancer. Nearly half of the ... bills, which was linked with a poorer health-related quality ...
(Date:12/19/2014)... Dennis Thompson HealthDay Reporter ... Ebola,s entrance into the United States -- along with ... outbreak -- have highlighted cracks in the nation,s public ... health policy report released Thursday. Half of U.S. ... to infectious disease outbreaks. That was the main conclusion ...
(Date:12/19/2014)... 19, 2014 Novellus Healthcare Communications, ... Pharmacy & Clinics™, an independent journal that provides ... and caring for patients inside the pharmacy and ... to provide optimal access to quality care, Inside ... for the team treating and coordinating patient care ...
(Date:12/19/2014)... December 19, 2014 From November 24, 2014, ... training for the year 2014 in its Goa retreat ... year. Through the Indian winters, from November to March, Siddhi ... beautiful beach of Arambol, Goa. The Goa training sessions will ... intakes of yoga teacher training, the 10th intake is also ...
Breaking Medicine News(10 mins):Health News:Preschoolers Need Eye Screening, Experts Say 2Health News:Cancer Treatment Costs Weigh Heavily on Patients, Study Finds 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 3Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 4Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 2Health News:The Transformation of Retail Pharmacies into a Healthcare Delivery Center 3Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 2Health News:Siddhi Yoga’s 10th intake of YTT started in Goa on November 24, 2014 3
... that not only modify diet and physical activity but ... lose weight and maintain that loss for at least ... adolescents the effect lasts for at least 12 months. ... change programs for adolescents may provide additional benefits. , ...
... 20 Exponent, Inc. (Nasdaq: EXPO ), today ... quarter and fiscal year ended January 2, 2009, immediately following ... The Company will host a corresponding conference call and ... Time. Michael Gaulke, Chairman and Chief Executive Officer, and ...
... tests, researchers say , , TUESDAY, Jan. 20 (HealthDay News) ... developing a saliva test for monitoring type 2 diabetes, ... the first time, researchers from Oregon and India have ... people with diabetes than in non-diabetics. Using these proteins, ...
... of patient,s condition, chances of recovery , , TUESDAY, Jan. 20 ... within the heart have been made by U.K. scientists using ... research shows that the amount of bleeding can indicate the ... of this kind of imaging, along with other tests, could ...
... HARRISBURG, Pa., Jan. 20 Consumers who purchased raw ... Lancaster County, should discard it immediately due to the ... today. Raw milk has not been pasteurized to kill ... must have a permit and have product samples tested ...
... Hospital & Medical Center and The Sports Medicine Clinic ... L. Smith, MD has joined the medical staff. He ... expertise in shoulder and elbow surgery.Dr. Smith received his ... School of Medicine in Springfield, IL. He completed ...
Cached Medicine News:Health News:Child and adolescent obesity: Family-based programs including behavior therapy can work 2Health News:Exponent to Announce Fourth Quarter and Fiscal Year 2008 Results 2Health News:Saliva Test Could Monitor Type 2 Diabetes 2Health News:MRI Scans Reveal Post-Heart Attack Bleeding 2Health News:Orthopaedic Surgeon Kevin Smith, MD, Joins Northwest Hospital & Medical Center and The Sports Medicine Clinic 2
... Misty Max 10 Nebulizer W/ 7` CR ... design for fast treatment times , ... (higher percentage of respirable particles) than conventional ... 10™ disposable nebulizers deliver fast and effective ...
... Nebulizer Disposable Prefilled 28%-100% FIO 2 ... ,Our prefilled nebulizers provide unmatched performance ... and cool high-output aerosols adjustable from 28% to ... selection of solutions: sterile water for inhalation, USP; ...
Nebulizer Custom Misty with Aerosol Mask...
Respirgard II Nebulizer System with Acorn II Nebulizer, 7' (2 m) supply tubing, universal "antidrool" tee, mouthpiece, 6" (15 cm) aerosol tube, wye, one-way valve and expiratory filter...
Medicine Products: